Results 121 to 130 of about 298,200 (325)
JPGN Reports, EarlyView.ABSTRACT Reactions to intravenous ustekinumab for inflammatory bowel disease (IBD) occur, the frequency of which is uncertain. It is unclear how often subcutaneous treatment is continued after reactions to the intravenous dose, or how well it is tolerated.
Joann Samalik +16 more
wiley +1 more source
BMC Cancer, 2009 Background Pancreatic cancer is an extremely aggressive malignancy. Subjects are afflicted with a variety of disconcerting symptoms, including profound cachexia. Recent data indicate that the outcome of oncological patients suffering from cancer cachexia
Rötzer Ingeborg +9 more
doaj +1 more source
Barbed Suture for Pancreaticojejunal Anastomosis: An Ally Against Pancreatic Fistula
Journal of Surgical Oncology, EarlyView.ABSTRACT Pancreaticoduodenectomy (PD) is the standard treatment for resectable pancreatic head disease. The pancreatic anastomosis constitutes the mainstay of this procedure and is one of the drivers of its morbidity. Despite the development of a variety of techniques for pancreaticojejunostomy or pancreaticogastrostomy, high rates of postoperative ...
Rosita Sortino +3 more
wiley +1 more source
Adjuvant pharmacological strategies for the musculoskeletal system during long‐term space missions
British Journal of Clinical Pharmacology, EarlyView., 2023 Abstract Despite 2 h of daily exercise training, muscle wasting and bone loss are still present after 6‐month missions to the international space station. Some crew members lose bone much faster than others. In preparation for missions to the Moon and Mars, space agencies are therefore reviewing their countermeasure portfolios.
Friederike Thomasius +2 more
wiley +1 more source
Liver Disease Predicts 30‐Day Postoperative Complications in Head and Neck Microvascular Surgery
The Laryngoscope, EarlyView.While liver disease is known to affect surgical outcomes, its impact on head and neck microvascular free tissue transfer surgeries remains unexamined. This study uses the NSQIP national database to analyze the relationship between liver disease severity, determined by APRI and MELD‐Na scores, and postoperative complications.
Anish R. Kosanam +4 more
wiley +1 more source
Parenteral lipid nutrition in congenital gastrointestinal malformation operated cases [PDF]
Background: Congenital gastrointestinal malformation (CGIM) cases require immediate surgical correction after birth and proper nutrition to meet energy demands. Among the macronutrients, lipids are considered the major energy source, playing a vital role
Blidisel, Alexandru +6 more
core +2 more sources
Lipids, EarlyView.ABSTRACT Long‐chain (LC) omega‐3 polyunsaturated fatty acids (PUFAs) like eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are crucial for optimal development, healthy aging, and disease management. Traditionally sourced from fatty fish, these omega‐3 PUFAs face sustainability challenges, prompting increased exploration of plant‐based ...
Ella J. Baker +2 more
wiley +1 more source
Parenteral glutamine in critical illness : just what the gut needs [PDF]
, 2012 The role of glutamine as a metabolic fuel for the starving intestines, its capacity to limit bacterial translocation, lung sepsis and a pro-inflammatory cytokine response are reviewed in the context of uncertainities regarding current recommendations for
Pullicino, Edgar
core
Intestinal transplantation: current status and latest developments. [PDF]
, 1999 Intestinal transplantation is no longer an experimental procedure and is the treatment of choice for patients with irreversible intestinal failure that cannot be maintained on total parenteral nutrition (TPN).
Doria, C, Marino, IR, Starzl, TE
core
Med Research, EarlyView.ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin +8 more
wiley +1 more source